What is HHS-HCC Commercial Risk Adjustment Model? Definition, Formula, and Benchmark

The HHS-HCC model is the risk-adjustment engine for the ACA commercial individual and small-group markets. Unlike CMS-HCC, which sets actual CMS payments to Medicare Advantage plans, HHS-HCC produces a risk-score-based transfer between ACA issuers — plans enrolling sicker-than-average members receive transfers from plans enrolling healthier-than-average members. The sum of transfers within each market and rating area is zero by design.

The model includes approximately 127 HCC categories specific to the commercial population, with coefficients that differ materially from the Medicare model. Conditions common to a younger commercial population — pregnancy, HIV, major depressive disorder, substance-use disorder, and several autoimmune categories — carry distinct coefficients in HHS-HCC that would be absent or differently weighted in CMS-HCC. Coefficients vary by age band (children, adults), metal tier (bronze, silver, gold, platinum, catastrophic), and rating area, producing a plan-member-level risk score that factors into the issuer's net transfer calculation.

The model is recalibrated annually by CMS and CCIIO. Plans submit EDGE server data — a prescribed set of claim and enrollment extracts — that CCIIO processes through the model to compute member-level risk scores and market-level transfers. Transfers are finalized and published each June following the benefit year. EDGE server completeness and accuracy is consequently a material financial priority for ACA issuers; incomplete data means forgone legitimate transfers to the plan.

HHS-HCC includes both a concurrent methodology (current-year diagnoses predict current-year spending) and prospective components for high-cost conditions. This differs from CMS-HCC's purely prospective approach and reflects the ACA market's lack of historical enrollment stability — members often enroll for a single plan year, so a prospective model using prior-year diagnoses would fail for new enrollees. The concurrent design does create retroactive payment variability: a diagnosis coded in Q4 can affect transfers finalized the following June.

Compliance and audit structure differs from the Medicare side. HHS-RADV is the commercial analog to CMS-RADV; it samples issuer charts to validate reported HCCs. Findings can cause plan-level error-rate adjustments to transfers. The statutory framework and appeal process are distinct from Medicare RADV but share the underlying mechanic of validating diagnosis-to-documentation chains.

Operationally, providers participating in ACA marketplace networks typically interact with HHS-HCC indirectly through plan risk-adjustment programs that look similar to Medicare Advantage programs — prospective chart review, documentation improvement, coding education on the specific ICD-10-CM codes that drive commercial HCCs. Providers in accountable-care arrangements with ACA plans may receive explicit HHS-HCC-adjusted quality and cost targets rather than CMS-HCC targets.